Comments

AbbVie

Q: What sector and industry does AbbVie (ABBV) operate in?

AbbVie is in the Health Care sector and Biotechnology industry. They are listed on the NYSE.

ABBVNYSE

Logo brought to you by Benzinga Data

Perks Buy Compare Brokers

$166.57

0.290.17%

At close: -

$166.90

0.330.20%

After Hours: 4:22 PM EDT

AbbVie (ABBV) Forecast

News Earnings AbbVie (ABBV) Options Guidance Dividends Analyst Ratings Insider Trades Government Trades Short Interest

Overview Rating

Speculative

Technicals Analysis

0100

Financials Analysis

0100

AbbVie (NYSE:ABBV) Stock Quotes, Forecast and News Summary

AbbVie Stock (NYSE: ABBV) stock price, news, charts, stock research, profile.

Open	$165.27
Close	$166.57
Volume / Avg.	5.23M / 5.33M
Day Range	$163.81 - $167.10
52 Wk Range	137.14 - 207.32
Market Cap	$294.72B
P/E Ratio	57.94
Dividend Yield	3.95%
Exchange	NYSE
RSI	26
Short Interest	1.03%
Days to Cover	3.1

Recent News

Super Micro Computer, Moderna And XPeng Were Among Top 10 Large Cap Stocks Losing Big Last Week (November 11-15): Check Out Other Losers

10 worst performing large-cap stocks last week: MPWR, SMCI, MRNA, LDOS, MNDY, PCVX, BAH, ABBV, CACI, XPEV. Check if they're in your portfolio.

Lekha Gupta

AbbVie, Bitcoin And An Energy Stock On CNBC's 'Final Trades'

AbbVie said two trials investigating emraclidine as a once-daily, oral monotherapy treatment for adults with schizophrenia failed two Phase 2 trials.

Avi Kapoor

Viking Fund Management Sells Big Oil Stocks In Q3, Cuts Tesla Position In Half, Adds To Largest Position Broadcom

A look at the moves made by Viking Fund management in the third quarter, including the exits and new stakes and fund's largest positions at the end of Q3.

Chris Katje

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Analyst Trends and Forecast

Jun

Jul

Aug

Oct

Nov

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

3.7

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Open	$165.27
Close	$166.57
Volume / Avg.	5.23M / 5.33M
Day Range	$163.81 - $167.10
52 Wk Range	137.14 - 207.32
Market Cap	$294.72B
P/E Ratio	57.94
Dividend Yield	3.95%
Exchange	NYSE
RSI	26
Short Interest	1.03%
Days to Cover	3.1

Compare

EPS better than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS better than industry

FAQ

How do I buy AbbVie (ABBV) stock?

You can purchase shares of AbbVie (NYSE:ABBV) through any online brokerage.

View our list of the best stock brokerages

Who are AbbVie (ABBV) competitors?

Other companies in AbbVie’s space includes: Sarepta Therapeutics (NASDAQ:SRPT), Exact Sciences (NASDAQ:EXAS), Neurocrine Biosciences (NASDAQ:NBIX), Roivant Sciences (NASDAQ:ROIV) and Amgen (NASDAQ:AMGN).

What is the forecast, or price target, for AbbVie (ABBV) stock?

AbbVie has a consensus price target of $189.93.

What is the current price for AbbVie (ABBV)?

The stock price for AbbVie (NYSE: ABBV) is $166.8984 last updated November 19, 2024 at 4:22 PM EST.

Does AbbVie (ABBV) pay a dividend?

The next AbbVie (ABBV) dividend date is projected to be Wednesday, January 15, 2025.

When is AbbVie (NYSE:ABBV) reporting earnings?

AbbVie’s Q4 earnings are confirmed for Friday, January 31, 2025.

Is AbbVie (ABBV) going to split?

There is no upcoming split for AbbVie.

What sector and industry does AbbVie (ABBV) operate in?

AbbVie is in the Health Care sector and Biotechnology industry. They are listed on the NYSE.